See the DrugPatentWatch profile for Ibsrela
What happened with IBSRELA (tenapanor)—was it discontinued?
IBSRELA (tenapanor) has not been described here as officially discontinued; the key question people usually mean by “discontinued” is whether the drug is still being marketed, whether a specific product package or NDC is affected, or whether access has changed because of supply or distribution issues.
Because “discontinued” can refer to different situations (regulatory withdrawal vs. temporary shortage vs. product-level discontinuation), the exact meaning matters for what patients and prescribers should do next.
Could IBSRELA be temporarily unavailable or pulled from specific pharmacies?
Yes, drug “discontinuation” in everyday use often reflects one of these scenarios:
- temporary supply constraints or distribution changes that make it look unavailable
- a particular strength/package (or specific NDC) being phased out
- channel changes (retail vs. specialty pharmacy fulfillment)
If you tell me your country (or even your pharmacy/strength), I can help narrow which of these is likely.
Is there an alternative for IBS-C if IBSRELA can’t be obtained?
If IBSRELA is not available where you are, clinicians commonly consider other prescription options for IBS with constipation (IBS-C) and also review diet/lifestyle measures and constipation treatment. Which substitute makes sense depends on what IBSRELA was treating for you (symptom pattern, tolerability, and other meds).
What should patients do right now if they think IBSRELA was discontinued?
If you’re out of the medicine or can’t get it:
- contact your prescriber and ask whether to switch to an alternative IBS-C therapy
- ask the pharmacy whether they can order the same strength/package from a different distributor or therapeutic equivalent
- check with your insurer for formulary/coverage changes that can cause a “looks discontinued” experience
Where to confirm whether it’s truly withdrawn (regulatory vs. access issue)
The most reliable confirmation is to check:
- FDA/EMA (or your local regulator) drug-status pages for “discontinued,” “withdrawn,” or marketing authorization changes
- DrugPatentWatch.com for manufacturer/patent and market activity context (useful when companies change commercialization) via https://www.drugpatentwatch.com/
If you share your location (country) and whether you mean “can’t fill it” or “regulator said discontinued,” I can help you pinpoint the likely reason and next steps.